KIDSKIDSHealthcare · Medical Devices

KIDS Stock Forecast: OrthoPediatrics Corp. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$32
−2.37% on the day

The 7 Wall Street analysts covering OrthoPediatrics Corp. hold a median 12-month price target of $33 — +2.4% from the last close. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 84 of 100 as at 21 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$828.7M
Ticker Nerd rank
84/ 100
Median analyst target
$33
Analysts covering
7
Revenue$70.5M+15.4% y/y
Operating income−$4.1M
Net income−$7.2M
Free cash flow−$3.1M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−1.9%
1M
+35.1%
YTD
+78.7%
1Y
+88.1%
From 52W high
−6.6%
From 52W low
+116.8%
$15
$34
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores OrthoPediatrics Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
84/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
87
Growth
85
Revisions
78
Volatility
75
Accruals
72
Value
56
Quality
54
Issuance
32

Momentum (87): The shares have been drifting up relative to others.

Issuance (32): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

KIDS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on KIDS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$10$20$30$40$50Jan 26Apr 26Jul 26Oct 26KIDSHigh $45Median $33Low $27

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says7 analysts
6
Buy
1
Hold
0
Sell
$27
Low
$33
Median
$45
High

The green dot is the last close — the median target sits +2.4% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 13 moved their price target up and 0 moved it down.

DateFirmActionRatingTarget
19 Nov 2026Piper SandlerReiteratesOverweight$30 → $45
18 Nov 2026BTIGMaintainsBuy$30 → $40
28 Oct 2026BTIGMaintainsBuy$29 → $30
28 Oct 2026Canaccord GenuityMaintainsBuy$28 → $30
28 Oct 2026Lake StreetMaintainsBuy$34 → $38
28 Oct 2026Piper SandlerReiteratesOverweight$25 → $30
28 Oct 2026StifelMaintainsBuy$24 → $27
28 Oct 2026TD CowenMaintainsBuy$23 → $28
28 Oct 2026Truist SecuritiesMaintainsHold$22 → $28
14 Sept 2026BTIGReiteratesBuy$29
20 Aug 2026BTIGMaintainsBuy$24 → $29
5 Aug 2026NeedhamMaintainsBuy$30 → $35
5 Aug 2026Piper SandlerReiteratesOverweight$22 → $25
16 July 2026Truist SecuritiesMaintainsHold$17 → $20
1 May 2026BTIGReiteratesBuy$24
2 Mar 2026Truist SecuritiesMaintainsHold—
27 Feb 2026BTIGMaintainsBuy—
27 Feb 2026NeedhamMaintainsBuy—
27 Jan 2026TD CowenInitiatesBuy—
10 Dec 2025Canaccord GenuityInitiatesBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for KIDS.

Market Radar

This page is one stock. Monday covers all of them.

KIDS appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

KIDS vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, OrthoPediatrics Corp. returned +88.1% against +6.9% for the S&P 500, dividends included.

KIDS vs S&P 500, last 12 monthsTotal return, rebased to 100
80100120140160180200Jan 26Apr 26Jul 26Oct 26KIDSS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

KIDS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
2
Analysts cutting
2
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
3.1×

Cheaper than 35% of US stocks

Price / book
2.4×

Cheaper than 37% of US stocks

EV / EBITDA
793.1×

Cheaper than 1% of US stocks

Growth & margins
Revenue growth (YoY)
18.6%

Higher than 68% of US stocks

Earnings growth (YoY)
—
Gross margin
74.3%

Higher than 87% of US stocks

Operating margin
−8.1%

Higher than 27% of US stocks

Net margin
−12.8%

Higher than 19% of US stocks

Returns & dividend
Return on equity
−9.8%

Higher than 37% of US stocks

Return on assets
−2.7%

Higher than 36% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • OrthoPediatrics Corp. has a market value of $828.7M and an enterprise value of $895.4M.

  • Revenue in the twelve months to 30 June 2026: $252.7M. The latest quarter grew 15.4% year on year.

  • Net income over the same four quarters: −$39.7M, a −15.7% net margin.

  • Diluted earnings per share, trailing twelve months: −$1.68.

  • Free cash flow in the twelve months to 30 June 2026: −$1.8M.

  • Shares outstanding: 26.1M.

  • OrthoPediatrics Corp. employs 602 people — $420K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 21 Nov 2026

Data provided by Twelve Data

Peers

KIDS and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
KIDSOrthoPediatrics Corp.$828.7M84
BVSBioventus, Inc.$832.5M93
CTKBCytek Biosciences, Inc.$790.4M95
AORTArtivion, Inc.$885.4M31
VREXVarex Imaging Corp.$758.7M81
INMDInMode Ltd.$713.9M85
BBNXBeta Bionics, Inc.$703.3M29

Take a look at KIDS’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own OrthoPediatrics Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about KIDS

What is the KIDS stock price forecast for 2026-2027?

The 7 Wall Street analysts covering OrthoPediatrics Corp. have a median 12-month price target of $33, with estimates ranging from $27 to $45. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is KIDS stock a buy right now?

Of the 7 analysts covering OrthoPediatrics Corp., 6 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks OrthoPediatrics Corp. 84 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank KIDS?

As at 21 Nov 2026, OrthoPediatrics Corp. ranks 84 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Momentum (87 of 100).

Will KIDS stock go up?

No one can know that. What the data says: the median 12-month target from 7 analysts implies +2.4% from the last close, and Ticker Nerd's factor model ranks OrthoPediatrics Corp. 84 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the KIDS stock forecast for 2030?

No analyst covering OrthoPediatrics Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for KIDS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $27 to $45 over the next 12 months.

How has KIDS stock performed over the past year?

OrthoPediatrics Corp. returned +88.1% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does OrthoPediatrics Corp. do?

OrthoPediatrics Corp. is a medical device company focused exclusively on pediatric orthopedics. It designs, develops, and markets anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions, supporting surgeons and caregivers in treating trauma and deformity correction, scoliosis, and sports medicine cases.

Company

About OrthoPediatrics Corp.

OrthoPediatrics Corp. is a medical device company focused exclusively on pediatric orthopedics. It designs, develops, and markets anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions, supporting surgeons and caregivers in treating trauma and deformity correction, scoliosis, and sports medicine cases. The company’s product portfolio includes surgical systems, pediatric nailing solutions, spinal care products, and specialty bracing technologies tailored to the needs of smaller and developing patients. OrthoPediatrics also operates orthopedic and prosthetic clinic services, extending its role beyond products to non-surgical care. Its business is centered on serving hospitals, children’s medical centers, and orthopedic specialists in the United States and international markets. Headquartered in Warsaw, Indiana, OrthoPediatrics occupies a specialized position in the medical technology market as a pediatric-only orthopedic platform.

CEO Mr. David R. Bailey · 602 employees · United States · https://www.orthopediatrics.com